Insulet Corp: Form 10-Q for the period ended Sep 30, 2013
Filed with the SEC on Nov 7, 2013 and accepted by EDGAR at Nov 7, 2013, 22:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-07-01 to 2013-09-30 | $61.1m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2013-01-01 to 2013-09-30 | $178.6m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2013-07-01 to 2013-09-30 | $33.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2013-01-01 to 2013-09-30 | $99.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2013-07-01 to 2013-09-30 | $27.4m | us-gaap:GrossProfit |
| Gross profit | 9 months2013-01-01 to 2013-09-30 | $79.4m | us-gaap:GrossProfit |
| Research and development | 3 months2013-07-01 to 2013-09-30 | $5.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2013-01-01 to 2013-09-30 | $15.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2013-07-01 to 2013-09-30 | −$17.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2013-01-01 to 2013-09-30 | −$29.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2013-07-01 to 2013-09-30 | $100.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2013-01-01 to 2013-09-30 | $100.0k | us-gaap:InterestExpense |
| Income tax | 3 months2013-07-01 to 2013-09-30 | $5.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2013-01-01 to 2013-09-30 | $254.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-07-01 to 2013-09-30 | −$21.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2013-01-01 to 2013-09-30 | −$42.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2013-07-01 to 2013-09-30 | −$0.39 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2013-01-01 to 2013-09-30 | −$0.79 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2013-01-01 to 2013-09-30 | $6.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2013-01-01 to 2013-09-30 | $4.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2013-09-30 | $153.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-09-30 | $199.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2013-09-30 | $289.5m | us-gaap:Assets |
| Current liabilities | At period end2013-09-30 | $48.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-09-30 | $168.1m | us-gaap:Liabilities |
| Long-term debt | At period end2013-09-30 | $111.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2013-09-30 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2013-09-30 | $121.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001145197-13-000035. Last ingested by Listed: Nov 4, 2026, 16:38 ET. Listed shows no prices and gives no investment advice.